StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Friday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens raised their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Check Out Our Latest Research Report on MDRX
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What Are the FAANG Stocks and Are They Good Investments?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What is a buyback in stocks? A comprehensive guide for investors
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is the FTSE 100 index?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
